Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites.
Jinxiu ZhuZhijun BaoZuoqi HuShenglin WuCuihong TianYueran ZhouZipeng DingXuerui TanPublished in: Nutrition & diabetes (2024)
Myricetin can prevent DCM development by increasing the abundance of beneficial gut microbiota and restoring the gut barrier function.